Charles River Laboratories International, Inc. (CRL)

CRL Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for CRL stock have an average target of 185.77, with a low estimate of 145 and a high estimate of 250. The average target predicts an increase of 60.31% from the current stock price of 115.89.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$145	$185.77	$175	$250
Change	+25.12%	+60.31%	+51.01%	+115.73%

Analyst Ratings

The average analyst rating for CRL stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	2	2	2	1	1
Buy	0	0	0	0	0	0
Hold	9	9	11	11	13	13
Sell	0	0	0	0	0	0
Strong Sell	2	2	2	2	1	1
Total	13	13	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luke Sergott Barclays	Barclays	Hold Maintains $160 → $145	Hold	Maintains	$160 → $145	+25.12%	Apr 10, 2025
Ann Hynes Mizuho	Mizuho	Hold Maintains $175 → $155	Hold	Maintains	$175 → $155	+33.75%	Apr 9, 2025
Matthew Sykes Goldman Sachs	Goldman Sachs	Strong Buy → Hold Downgrades $190 → $170	Strong Buy → Hold	Downgrades	$190 → $170	+46.70%	Mar 21, 2025
Patrick Donnelly Citigroup	Citigroup	Strong Sell → Hold Upgrades $155 → $175	Strong Sell → Hold	Upgrades	$155 → $175	+51.01%	Mar 4, 2025
Casey Woodring JP Morgan	JP Morgan	Hold Maintains $175 → $165	Hold	Maintains	$175 → $165	+42.38%	Feb 20, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.86B

Decreased by -4.72%

from 4.05B

Revenue Next Year

3.99B

Increased by 3.27%

from 3.86B

EPS This Year

9.42

Increased by 4,610.40%

from 0.20

EPS Next Year

10.16

Increased by 7.83%

from 9.42

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 26, 2020	Dec 25, 2021	Dec 31, 2022	Dec 30, 2023	Dec 28, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.92B	3.54B	3.98B	4.13B	4.05B	3.86B	3.99B	4.17B
Revenue Growth	11.55%	21.08%	12.31%	3.86%	-1.92%	-4.72%	3.27%	4.59%
EPS	7.20	7.60	9.48	9.22	0.20	9.42	10.16	11.29
EPS Growth	42.01%	5.56%	24.74%	-2.74%	-97.83%	4,610.40%	7.83%	11.11%
Forward PE	-	-	-	-	-	12.30	11.41	10.27
No. Analysts	-	-	-	-	-	22	22	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	4.1B	4.3B	4.8B
Avg	3.9B	4.0B	4.2B
Low	3.7B	3.4B	2.7B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	0.6%	11.6%	20.2%
Avg	-4.7%	3.3%	4.6%
Low	-8.8%	-13.0%	-32.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	9.96	11.15	12.75
Avg	9.42	10.16	11.29
Low	8.92	9.28	10.05

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	4,882.3%	18.4%	25.5%
Avg	4,610.4%	7.8%	11.1%
Low	4,359.0%	-1.5%	-1.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.